Description
CJC-1295 & Ipamorelin Blend Product Description
CJC-1295 & Ipamorelin Blend combines two synthetic peptides that work through complementary pathways to stimulate the body’s natural release of growth hormone (GH). The CJC-1295 peptide (Mod GRF 1-29, No DAC) mimics growth hormone-releasing hormone (GHRH), while Ipamorelin acts as a selective ghrelin receptor agonist. Together, they promote pulsatile growth hormone release, leading to increased insulin-like growth factor-1 (IGF-1) production without directly supplying exogenous growth hormone.
Researchers frequently investigate this peptide combination because each compound targets a different signaling pathway involved in growth hormone secretion. CJC-1295 helps prolong the natural GHRH signal, while Ipamorelin stimulates growth hormone release through the ghrelin receptor with minimal impact on cortisol and prolactin levels compared with earlier growth hormone secretagogues.
CJC-1295 & Ipamorelin Blend Makeup
Molecular Formula:
- CJC-1295: C152H252N44O42
- Ipamorelin: C38H49N9O5
Molecular Weight:
- CJC-1295: 3367.9 g/mol
- Ipamorelin: 711.8 g/mol
Other Known Titles
- CJC-1295: CJC-1295 NO DAC; Mod GRF 1-29
- Ipamorelin: NNC 26-0161
CJC-1295 & Ipamorelin Blend Benefits
Preclinical research has explored the CJC-1295 & Ipamorelin Blend for several potential biological effects, including:
- Supports natural growth hormone release by stimulating complementary GH signaling pathways.
- May increase IGF-1 production, supporting normal anabolic signaling.
- Lean muscle support through improved protein synthesis and positive nitrogen balance observed in research.
- Body composition support by promoting fat metabolism while helping preserve lean muscle mass.
- Exercise recovery support through increased cellular repair and collagen production.
- Bone and connective tissue research involving tissue remodeling and regeneration.
- Sleep quality support through growth hormone-related physiological pathways.
- Metabolic health research, including insulin utilization and nutrient partitioning.
- Digestive system support, with studies suggesting improved gastric emptying and gastrointestinal motility associated with Ipamorelin.
CJC-1295 & Ipamorelin Blend Effects
Research suggests this peptide combination may produce several biological effects:
- Promotes pulsatile growth hormone secretion
- Increases circulating IGF-1 levels
- Supports lean muscle development
- Encourages healthy fat metabolism
- Improves recovery following physical stress
- Supports collagen synthesis and connective tissue repair
- May enhance sleep quality and overnight recovery
- Supports healthy metabolic function and positive nitrogen balance
- May improve gastric motility through ghrelin receptor activation
Most available evidence comes from laboratory studies, animal research, and a limited number of human investigations involving the individual peptides. Larger clinical trials evaluating the combination remain limited.
CJC-1295 & Ipamorelin Blend Dosage
- Starting cjc 1295 ipamorelin dosage: 6 units (0.6 mg) daily in week one, escalating to 20 units (2.0 mg) by month two.
- Injection timing: Administer before bedtime, at least two hours after your last meal, to align with natural GH pulsatility.
- Cycle structure: 1 to 3 months on therapy, followed by 2 to 3 months off, with a 5-days-on, 2-days-off weekly schedule.
- CJC 1295 ipamorelin benefits: Support for lean muscle growth, fat metabolism, deeper sleep, faster recovery, and improved energy levels.
- Clinical oversight required: Dosage adjustments, reconstitution, and injection technique should always be guided by a licensed provider.
CJC-1295 Ipamorelin vs Tesamorelin
When comparing Tesamorelin with the CJC-1295 & Ipamorelin Blend, the key difference lies in their mechanism of action and therapeutic focus. Tesamorelin offers a more targeted approach to growth hormone stimulation, while the CJC-1295 & Ipamorelin combination provides broader support by activating two complementary pathways involved in natural growth hormone release. Comparing the benefits of both peptides side by side makes it easier to determine which option best aligns with specific health and performance goals. Here’s how they compare across the factors that matter most.
| Tesamorelin | CJC-1295 / Ipamorelin | |
|---|---|---|
| Primary target | Visceral abdominal fat | Broad GH optimization |
| FDA status | FDA-validated peptide (EGRIFTA SV brand approved for HIV lipodystrophy; compounded version prescribed at Perfect B) | Prescribed via compounding pharmacy |
| GH stimulation pathway | GHRH receptor only | GHRH + ghrelin receptor (dual) |
| Best for | Fat loss, body composition | Recovery, sleep, anti-aging, muscle |
| Injection frequency | Once daily | Once daily |
| Timeline to results | 2 months (2 cycles) | 2 months (2 cycles) |
The key distinction is that Tesamorelin provides a more targeted approach to stimulating growth hormone activity, whereas the CJC-1295 & Ipamorelin Blend offers broader, system-wide support by activating multiple growth hormone pathways. Neither peptide is inherently better than the other. The most suitable option depends on your individual goals, whether you are looking for a focused solution or a more comprehensive approach to growth hormone support and overall body composition.
